Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-026799
Filing Date
2017-11-17
Accepted
2017-11-17 16:41:33
Documents
1
Period of Report
2017-11-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2807
  Complete submission text file 0000899243-17-026799.txt   4260
Mailing Address 44 WALL STREET 12TH FLOOR NEW YORK NY 10005
Business Address 44 WALL STREET 12TH FLOOR NEW YORK NY 10005 646-205-1603
TYME TECHNOLOGIES, INC. (Issuer) CIK: 0001537917 (see all company filings)

EIN.: 453864597 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 44 WALL STREET, 12TH FLOOR NEW YORK NY 10005
Business Address
Eckard Jonathan (Reporting) CIK: 0001723096 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38169 | Film No.: 171211548